Tools
🔬 Training Transformers to solve 95% failure rate of Cancer Trials — Ron Alfa & Daniel Bear, Noetik
Noetik uses transformer neural networks and machine learning to improve cancer drug trial success rates, addressing the historically high failure rate (95%) in clinical development. The approach lever
Noetik uses transformer neural networks and machine learning to improve cancer drug trial success rates, addressing the historically high failure rate (95%) in clinical development. The approach leverages AI to better predict treatment efficacy and patient outcomes, potentially accelerating drug discovery and reducing the cost and timeline of cancer research trials.
Related
- Training and Finetuning Multimodal Embedding & Reranker Models with Sentence Transformers
- Training code and models are live on Hugging Face. Dan Fu (Together AI's VP of Kernels) led the work. Together AI provided compute. Blog: ht…
- Parcae: Doing more with fewer parameters using stable looped models
Source: Latent Space | 2026-04-20